| Literature DB >> 36061452 |
Christopher Vélez1, Mary Paz1, Kristina Skarbinski1, Christina Minami2, Helen Burton Murray1, Regan Bergmark2, Kyle Staller1, Braden Kuo1.
Abstract
Objective: Normal elective outpatient care has been impacted during the COVID-19 pandemic, due to limitations imposed by healthcare systems. Clear communication is necessary to address patient concerns as resumption of elective care gains pace.Entities:
Keywords: Coronavirus; Endoscopy; Pandemic; Telemedicine
Year: 2022 PMID: 36061452 PMCID: PMC9422815 DOI: 10.1016/j.pecinn.2022.100048
Source DB: PubMed Journal: PEC Innov ISSN: 2772-6282
The semi-structured interview of patients with delayed gastrointestinal testing. Two individuals performed 30 interviews of patients with delayed gastrointestinal motility testing at our institution, with the same call script used by both interviewers. There were minimal prompts to allow patients to freely express their experience with delayed testing, their health, their interactions with the healthcare system, as well as describe their own conceptions of the pandemic.
| Patient Background, Testing, Perspectives, and Self-Assessment | |||||
|---|---|---|---|---|---|
| Percent total (N) | Percent total (N) | Percent total (N) | |||
| Demographics/ Socioeconomics | Type of Diagnostic Testing | Satisfaction/ Concern with Testing Delay | |||
| Gender | Catheter-based foregut testing | 30 (9) | Upset gastrointestinal testing was delayed | ||
| Female | 66.7 (20) | Esophageal manometry (HREM) | 10 (3) | Not at all upset | 50 (15) |
| Male | 33.3 (10) | Catheter pH testing | 10 (3) | Mildly/ moderately upset | 20 (6) |
| HREM and pH testing | 10 (3) | Severely/ extremely upset | 13.3 (4) | ||
| White | 83.3 (25) | No response given | 16.7 (5) | ||
| Non-White | 16.7 (5) | EGD1 and wireless pH testing2 | 3.3 (1) | ||
| EGD and EndoFLIP3 | 13.3 (4) | Not at all concerned | 26.7 (8) | ||
| 18–24 | 3.3 (1) | EGD alone | 10 (3) | Mildly/ moderately concerned | 43.3 (13) |
| 25–34 | 10 (3) | Severely/ extremely concerned | 13.3 (4) | ||
| 35–44 | 13.3 (4) | Anorectal manometry | 43.3 (13) | No response given | 16.7 (5) |
| 45–54 | 20 (6) | ||||
| 55–64 | 40 (12) | ||||
| 65–74 | 10 (3) | Poor/ fair | 23.3 (7) | ||
| Over 75 | 3.3 (1) | Dysphagia (not specified) | 3.3 (1) | Good | 30 (9) |
| Achalasia | 16.7 (5) | Very good/ excellent | 30 (9) | ||
| Below $10,000 | 3.3 (1) | GERD4 | 30 (9) | No response given | 16.7 (5) |
| $10,001–$50,000 | 10 (3) | Lung transplantation | 6.7 (2) | ||
| $50,001–$100,000 | 26.7 (8) | Poor/ fair | 20 (6) | ||
| $100,001, $150,000 | 20 (6) | Constipation | 30 (9) | Good | 30 (9) |
| Over $150,000 | 13.3 (4) | Fecal incontinence | 13.3 (4) | Very good/ excellent | 33.3 (10) |
| No response given | 26.7 (8) | No response given | 16.7 (5) | ||
Baseline demographic data, diagnostic testing parameters, and patient assessments Patients with delayed gastrointestinal testing were overwhelmingly female and White although there was representation of male voices and those of people-of-color. Given age-based prevalence of gastrointestinal disease, it is not surprising the majority of patients were aged 55 or older. Household income tended to reflect those of favorable socioeconomic status although 26.7% did not provide information on annual household income. Percentages may not add up to 100% due to rounding.
| Qualitative Protocol for Semi-structured Interview in Patients with Delayed Testing | |
|---|---|
| Question category | Question example |
| Opening questions | Can you tell me briefly about what motility/ endoscopy test(s) you were scheduled to have? |
| What were you expecting to hear at your first appointment with the physician? | |
| How did your expectations differ from what you were actually told? | |
| Patient's experience during the COVID-19 pandemic | I am worried about COVID-19 infection and its consequences on my health and daily life. 1-Very little, 2-A little, 3-Some, 4- Much, 5-Very much |
| How have your thoughts regarding your safety from COVID changed since the start of the pandemic? | |
| How, if at all, has the COVID pandemic impacted your expectations regarding your treatment? | |
| Patient's thoughts on motility/ endoscopy testing delays due to the COVID-19 pandemic | What were you told about the need to delay your motility/ endoscopy test? |
| How much worry have you been experiencing related to your health? | |
| How did your family/ friends react to the news that your motility/ endoscopy test would be delayed? | |
| Everything considered, which would you say has worried you more: COVID or your gastrointestinal/ motility problem? | |
| Closing | Is there anything else you would like to tell us about your experience as a patient during the COVID-19 pandemic? |
Testing modalities listed include:
(1) EGD or esophagogastroduodenoscopy.
(2) wireless pH testing or BRAVO™.
(3) functional luminal imaging probe or EndoFLIP™ .
Disease states include:
(4) GERD or “gastroesophageal reflux disease” which coincided with additional diagnoses such as Barrett's esophagus or esophagitis and other complaints such as chronic cough, dysphagia, or globus sensation.
There was varying degrees of dissatisfaction and concern with gastrointestinal testing delay. Despite a cohort derived from those awaiting motility testing, there was a balanced self-assessment of overall quality of life and mental health.
Fig. 1Integrated framework of patient perspectives into the shared decision making model. Our methods revealed that patient perceptions to disrupted gastrointestinal care were highly variable with themes centering on patient-specific factors, pandemic-related factors, and healthcare function informing patients' initial preferences surrounding resumption of subspecialty care. They are adapted from description of the model described by Elwyn et al [29], represented here in green, blue, and yellow. Within each of the 3 themes (represented in pink), there are at times diametrically opposed conceptions that can be resolved via the used of the shared decision making model between patients and providers to move towards resumption of care through thoughtful patient-focused deliberation and communication. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
(1) Vaccination was not queried officially as interviews occurred summer 2020 before vaccines were available. Undoubtedly, vaccination status (of patients, healthcare workers) would influence patient's perception of risk.
Simplified framework matrix. A sample of questions that were asked as part of the semi-structured interviewed is represented with sample codes that derive from patient quotations. During transcript analysis, 4 “parent” codes categorized a total of 30 “child” codes, which themselves were grouped into 151 subsidiary codes.
| Sample Question | Sample Codes | Sample Quotes |
|---|---|---|
| How much worry have you been experiencing in the past week related to the COVID pandemic? | Predisposing condition making COVID-19 infection worse Worsened overall health Restrictions themselves will make me ill Health overall improving. | |
| What were you told about the need to delay your motility/endoscopy test? What were your initial reactions to this news? | Support at home Glad testing was canceled Disappointment testing was canceled Everyone is focusing on COVID-19 but I'm sick from not-COVID reasons. | But I wasn't phased by it. Actually, I was kind of relieved. I didn't want to go in while they were still trying to figure out what was going on.” |
| How did your family/friends react to the news that your motility/endoscopy test would be delayed until the end of the pandemic? How has their input influenced your views of the situation | Relatives had medical care deferred as well Relatives in healthcare explained delay Provided reassurance Concern about patient getting ill | |
| Everything considered, which would you say has you worred more: COVID or your gastrointestinal/motility problem? | Not understanding a lot about a new virus Because disease could be decompensating Gastrointestinal illness will be around after the pandemic is over | “I would say COVID, and I say that because– I keep referring back to the GI problem is underlying to a much bigger issue. So if that issue were thrown in the mix, it would be scleroderma first and then COVID” |
Fig. 2Approaching disrupted gastrointestinal care. Qualitative methods allow for a patient-centered assessment of potential barriers in care, thus identifying ways in which to address these barriers, to come up with solutions that promote resumption of elective care as pandemic parameters progress.